Sunwin Stevia International (SUWN) Stock Price, News & Analysis

Company Overview

Sunwin Stevia International (OTCMKTS:SUWN) is a specialty ingredient company focused on the cultivation, extraction and commercialization of stevia-derived sweeteners. Leveraging integrated operations that span agricultural sourcing through finished-product formulation, the company aims to provide natural, zero-calorie alternatives to sugar for food, beverage and nutraceutical customers worldwide. Sunwin Stevia’s core business centers on developing high-purity stevioside and rebaudioside extracts from stevia leaves, serving as a supplier of key raw materials used in low-calorie formulations.

Sunwin Stevia’s product portfolio includes bulk steviol glycosides as well as proprietary blends designed to optimize taste profiles in applications ranging from soft drinks and dairy products to tabletop sweeteners and dietary supplements. The company invests in research and development to enhance downstream processing efficiencies and to broaden the functional uses of stevia extracts. Its production infrastructure integrates extraction, purification and quality-control laboratories, enabling compliance with global food-safety standards and regulatory requirements.

While headquartered in Hong Kong, Sunwin Stevia International sources its stevia leaf from contract growers in Asia and maintains distribution channels across key markets in North America, Europe and the Asia-Pacific region. Management has emphasized partnerships with beverage and food manufacturers to accelerate adoption of natural sweeteners amid rising consumer demand for clean-label ingredients. As the market for sugar alternatives continues to expand, Sunwin Stevia seeks to leverage its end-to-end supply chain and extraction expertise to meet evolving industry needs.

Key Stats

• Today's Range: $0.0001 to $0.0001
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0003
• Volume: 30,000 shs
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SUWN Stock Analysis - Frequently Asked Questions

How have SUWN shares performed this year?

Sunwin Stevia International's stock was trading at $0.0001 at the beginning of 2025. Since then, SUWN shares have increased by 0.0% and is now trading at $0.0001.

How do I buy shares of Sunwin Stevia International?

Shares of SUWN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Sunwin Stevia International own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Sunwin Stevia International investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Heatwurx (PCSA), Akero Therapeutics (AKRO), CymaBay Therapeutics (CBAY), Cumberland Pharmaceuticals (CPIX) and Entasis Therapeutics (ETTX).

Company Calendar

• Today: 10/11/2025
• Fiscal Year End: 4/30/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - GENERIC DRG
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:SUWN
• CIK: 806592
• Web: www.sunwininternational.com
• Phone: 86-53-7442-4999
• Fax: 86-53-7441-3350
• Employees: 240
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A